First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study (Q28538326)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 2014)

Language	Label	Description	Also known as
English	First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study	scientific article (publication date: 2014)

Statements

scholarly article

0 references

First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study (English)

0 references

HIV transmission

0 references

0 references

Claudia Kücherer

3

object named as

Claudia Kücherer

0 references

author name string

Fabia Zu Knyphausen

1

0 references

Ramona Scheufele

2

0 references

Klaus Jansen

4

0 references

Sybille Somogyi

5

0 references

Stephan Dupke

6

0 references

Heiko Jessen

7

0 references

Dirk Schürmann

8

0 references

Osamah Hamouda

9

0 references

Karolin Meixenberger

10

0 references

Barbara Bartmeyer

11

0 references

language of work or name

0 references

publication date

2014

0 references

0 references

9

0 references

5

0 references

e95956

0 references

copyright license

Creative Commons Attribution 4.0 International

1 May 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

19 March 2017

Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

19 March 2017

Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

19 March 2017

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

19 March 2017

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

19 March 2017

Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

19 March 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

7 April 2017

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Class-sparing regimens for initial treatment of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Epidemiology of antiretroviral drug resistance in drug-naïve persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

An automated genotyping system for analysis of HIV-1 and other microbial sequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Declining trend in transmission of drug-resistant HIV-1 in Amsterdam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Time trends in primary HIV-1 drug resistance among recently infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

29 September 2017

Update of the drug resistance mutations in HIV-1: March 2013.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

3 June 2018

Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

3 June 2018

Transmission of drug-resistant HIV-1 is stabilizing in Europe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

3 June 2018

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Transmitted Drug Resistant HIV-1 and Association With Virologic and CD4 Cell Count Response to Combination Antiretroviral Therapy in the EuroSIDA Study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0095956

21 January 2018

Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

27 November 2018

Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

27 November 2018

HIV-1 subtype B epidemic and transmission patterns in Slovenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

27 November 2018

Declining prevalence of HIV-infected individuals at risk of transmitting drug-resistant HIV in Denmark during 1997-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

27 November 2018

Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4006817

27 November 2018

[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24788613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24788613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends of prevalence of primary HIV drug resistance in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/24788613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/24788613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low prevalence of transmitted antiretroviral drug resistance in a large UK HIV-1 cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/24788613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transmission of HIV‐1 Drug‐Resistant Variants: Prevalence and Effect on Treatment Outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24788613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain

1 reference

https://pubmed.ncbi.nlm.nih.gov/24788613

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0095956

0 references

2014PLoSO...995956Z

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28538326&oldid=1861887635"